drugset / Trial / NCT04775030

Methodology for Developing an Occlusal Appliance With CBD Active Carrier

NCT04775030

Phase 2/3 Unknown 40 enrolled Medical University of Silesia
RandomizedParallel-groupDouble-blindTreatment

Summary

Evaluation of the efficacy of the occlusal appliance with active cannabidiol (CBD) molecules in TMD patients

Timeline

Start
2021-01-01
Primary completion
2022-01-01
Completion
2023-01-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabidiol Other / unclassified Oral